Postmenopausában kialakuló endometrium hyperplasia eredményes aromatáz-inhibitor-kezelése nagyfokú obesitas esetében

Translated title of the contribution: Effective aromatase inhibitor treatment of endometrium hyperplasia in an obese postmenopausal woman

Koloszár Sándor, Pál Zoltán, Keresztúri Attila Es, A. Pál

Research output: Contribution to journalArticle

Abstract

In this study the authors investigated the efficacy of the aromatase inhibitor anastrazole in treating endometrial hyperplasia and postmenopausal bleeding in an obese 65 years old woman. They administered anastrazole for 12 months to an obese postmenopausal woman with high operative risk. Prior to the aromatase inhibitor treatment progestin administration proved ineffective in this case. During the treatment period the endometrial thickness changed from 9.8 mm to 2.4 mm and the result of the control endometrial histology was endometrium - atrophy. In the investigated period there was no uterine bleeding. Aromatase inhibitor treatment appears to be a new treatment modality in endometrial hyperplasia in obese postmenopausal women.

Original languageHungarian
Pages (from-to)237-239
Number of pages3
JournalMagyar Noorvosok Lapja
Volume70
Issue number4
Publication statusPublished - 2007

Fingerprint

Aromatase Inhibitors
Endometrium
Hyperplasia
Endometrial Hyperplasia
Uterine Hemorrhage
Progestins
Therapeutics
Atrophy
Histology
Hemorrhage
anastrozole

ASJC Scopus subject areas

  • Obstetrics and Gynaecology

Cite this

Postmenopausában kialakuló endometrium hyperplasia eredményes aromatáz-inhibitor-kezelése nagyfokú obesitas esetében. / Sándor, Koloszár; Zoltán, Pál; Attila Es, Keresztúri; Pál, A.

In: Magyar Noorvosok Lapja, Vol. 70, No. 4, 2007, p. 237-239.

Research output: Contribution to journalArticle

Sándor, Koloszár ; Zoltán, Pál ; Attila Es, Keresztúri ; Pál, A. / Postmenopausában kialakuló endometrium hyperplasia eredményes aromatáz-inhibitor-kezelése nagyfokú obesitas esetében. In: Magyar Noorvosok Lapja. 2007 ; Vol. 70, No. 4. pp. 237-239.
@article{64017d45c0f84b4fbdd1d418b850c7a0,
title = "Postmenopaus{\'a}ban kialakul{\'o} endometrium hyperplasia eredm{\'e}nyes aromat{\'a}z-inhibitor-kezel{\'e}se nagyfok{\'u} obesitas eset{\'e}ben",
abstract = "In this study the authors investigated the efficacy of the aromatase inhibitor anastrazole in treating endometrial hyperplasia and postmenopausal bleeding in an obese 65 years old woman. They administered anastrazole for 12 months to an obese postmenopausal woman with high operative risk. Prior to the aromatase inhibitor treatment progestin administration proved ineffective in this case. During the treatment period the endometrial thickness changed from 9.8 mm to 2.4 mm and the result of the control endometrial histology was endometrium - atrophy. In the investigated period there was no uterine bleeding. Aromatase inhibitor treatment appears to be a new treatment modality in endometrial hyperplasia in obese postmenopausal women.",
keywords = "Aromatase inhibitor treatment, Endometrial hyperplasia, Menopause, Obesity",
author = "Kolosz{\'a}r S{\'a}ndor and P{\'a}l Zolt{\'a}n and {Attila Es}, Kereszt{\'u}ri and A. P{\'a}l",
year = "2007",
language = "Hungarian",
volume = "70",
pages = "237--239",
journal = "Magyar Noorvosok Lapja",
issn = "0025-021X",
publisher = "Magyar Noovos Tarsasag",
number = "4",

}

TY - JOUR

T1 - Postmenopausában kialakuló endometrium hyperplasia eredményes aromatáz-inhibitor-kezelése nagyfokú obesitas esetében

AU - Sándor, Koloszár

AU - Zoltán, Pál

AU - Attila Es, Keresztúri

AU - Pál, A.

PY - 2007

Y1 - 2007

N2 - In this study the authors investigated the efficacy of the aromatase inhibitor anastrazole in treating endometrial hyperplasia and postmenopausal bleeding in an obese 65 years old woman. They administered anastrazole for 12 months to an obese postmenopausal woman with high operative risk. Prior to the aromatase inhibitor treatment progestin administration proved ineffective in this case. During the treatment period the endometrial thickness changed from 9.8 mm to 2.4 mm and the result of the control endometrial histology was endometrium - atrophy. In the investigated period there was no uterine bleeding. Aromatase inhibitor treatment appears to be a new treatment modality in endometrial hyperplasia in obese postmenopausal women.

AB - In this study the authors investigated the efficacy of the aromatase inhibitor anastrazole in treating endometrial hyperplasia and postmenopausal bleeding in an obese 65 years old woman. They administered anastrazole for 12 months to an obese postmenopausal woman with high operative risk. Prior to the aromatase inhibitor treatment progestin administration proved ineffective in this case. During the treatment period the endometrial thickness changed from 9.8 mm to 2.4 mm and the result of the control endometrial histology was endometrium - atrophy. In the investigated period there was no uterine bleeding. Aromatase inhibitor treatment appears to be a new treatment modality in endometrial hyperplasia in obese postmenopausal women.

KW - Aromatase inhibitor treatment

KW - Endometrial hyperplasia

KW - Menopause

KW - Obesity

UR - http://www.scopus.com/inward/record.url?scp=34547573646&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547573646&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:34547573646

VL - 70

SP - 237

EP - 239

JO - Magyar Noorvosok Lapja

JF - Magyar Noorvosok Lapja

SN - 0025-021X

IS - 4

ER -